Atherogenic dyslipidemia

Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, elevated levels of large TG rich very low-density lipoproteins, apolipoprotein B and oxidised low-density lipoprotein (LDL), and reduced levels of small high-density lipoproteins plays a critical role in AD. All three elements of AD per se have been recognised as independent risk factor for cardiovascular disease. LDL-C/HDL-C ratio has shown excellent risk prediction of coronary heart disease than either of the two risk markers. Asian Indians have a higher prevalence of AD than western population due to higher physical inactivity, low exercise and diet deficient in polyunsaturated fatty acids (PUFA). The AD can be well managed by therapeutic lifestyle changes with increased physical activities, regular exercise, and diets low in carbohydrates and high in PUFA such as omega-3-fatty acids, as the primary intervention. This can be supplemented drug therapies such as statin monotherapy or combination therapy with niacin/fibrates. Rosuvastatin is the only statin, presently available, to effectively treat AD in diabetes and MS patients.

• Publication year

  2013

• Venue

  Indian journal of endocrinology and metabolism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/2230-8210.122600PMID 24381869PMCID 3872713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Lipid parameters for measuring risk of cardiovascular disease

  2011cited by this paper
• Dysfunctional HDL as a diagnostic and therapeutic target.

  2010cited by this paper
• Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention

  2010cited by this paper
• HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.

  2009cited by this paper
• Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

  2009cited by this paper
• Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.

  2009cited by this paper
• Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

  2008cited by this paper
• Spotlight on HDL-raising therapies: insights from the torcetrapib trials

  2008cited by this paper
• Population variations in atherogenic dyslipidemia: A report from the HeartSCORE and IndiaSCORE Studies.

  2008cited by this paper
• The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk

  2008cited by this paper
• Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

  2008cited by this paper
• Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.

  2008cited by this paper
• High-density lipoprotein as a therapeutic target: a systematic review.

  2007cited by this paper
• Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease

  2007cited by this paper
• Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.

  2007cited by this paper
• Significance of Small Dense Low-Density Lipoprotein as a Risk Factor for Coronary Artery Disease and Acute Coronary Syndrome

  2006cited by this paper
• Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.

  2006cited by this paper
• Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss

  2006cited by this paper
• Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

  2005cited by this paper
• Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.

  2005cited by this paper
• A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study.

  2005cited by this paper
• Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group.

  2005cited by this paper
• The metabolic basis of atherogenic dyslipidemia.

  2005cited by this paper
• Risk stratification of dyslipidemia: insights from the Framingham Study.

  2005cited by this paper
• Metabolic syndrome: definition, pathophysiology, and mechanisms.

  2005cited by this paper
• Diabetic dyslipidaemia: from basic research to clinical practice*

  2003cited by this paper
• Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress

  2003cited by this paper
• Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria.

  2003cited by this paper
• Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women

  2002cited by this paper
• Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial.

  2002cited by this paper
• Intra‐urban differences in the prevalence of the metabolic syndrome in southern India – the Chennai Urban Population Study (CUPS No. 4)

  2001cited by this paper
• The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

  2001cited by this paper
• Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms.

  2000cited by this paper
• Vitamin E and heart disease: basic science to clinical intervention trials.

  2000cited by this paper
• Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.

  1999cited by this paper
• Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.

  1998cited by this paper
• Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands.

  1998cited by this paper
• Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells.

  1998cited by this paper
• Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells.

  1998cited by this paper
• Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells.

  1998cited by this paper
• Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.

  1997cited by this paper
• The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers.

  1997cited by this paper
• Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation.

  1996cited by this paper
• Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation. Role of P-selectin.

  1995cited by this paper
• Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.

  1993cited by this paper
• Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment

  1992cited by this paper
• A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

  1991cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper
• Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

  1990cited by this paper
• Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.

  1988cited by this paper
• Circadian patterns in coronary disease: the mournfulness of morning.

  1988cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper

• Association between dietary pattern, atherogenic index of plasma, and cardiovascular disease risk factors amongst adults: A cross-sectional cohort-based study.

  2026cites this paper
• Consensus Statements on Dyslipidemia in Indian Women

  2025cites this paper
• The modified cardiometabolic index as a simple screening tool for cardiovascular disease risk: a cohort study

  2025cites this paper
• Association between the atherogenic index of plasma and long-term prognosis in acute ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: a retrospective cohort study

  2025cites this paper
• Altered Lipid Profiles and Increased Cardiovascular Risk in Behçet's Disease: A Link Between Low HDL-C and Neurological Involvement

  2025cites this paper
• Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain

  2025cites this paper
• Metabolic Signatures in Lean MASLD: Current Insights and Future Directions

  2025cites this paper
• Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension.

  2025cites this paper
• Role of medicinal plants in ameliorating the lipid and glucose levels in diabetes: A systematic literature review

  2025cites this paper
• Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition

  2025cites this paper
• The combined effects of cardiometabolic index and high-sensitivity C-reactive protein on the risk of new onset stroke in a Chinese national prospective longitudinal cohort study

  2025cites this paper
• Unveiling the Complex Relationship between Polycystic Ovary Syndrome and Cardiovascular Risk Factors: A Comprehensive Review

  2025cites this paper
• [Usefullness of different scales of overweight and obesity to predict the presence of atherogenic dyslipidemia and lipid triad in 418,343 spanish workers].

  2024cites this paper
• Dietary Effects of Fasting on the Lipid Panel

  2024cites this paper
• Association between Atherogenic Dyslipidemia and Subclinical Myocardial Injury in the General Population

  2024cites this paper
• The in vitro effect of myeloperoxidase oxidized LDL on THP-1 derived macrophages

  2024cites this paper
• Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.

  2024cites this paper
• Purple Sweet Potato Extract and Aerobic Exercise Reduce Lipid Profiles in Hyperlipidemic Rats Model

  2024cites this paper
• Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population.

  2024cites this paper
• Long Way of Evaluating Niacin for Atherosclerosis Treatment

  2024cites this paper
• Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024

  2024cites this paper
• Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients

  2024cites this paper
• The value of Lp(a) and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke

  2024cites this paper
• Osteopontin as an early predictor of atherosclerosis in attack-free Familial Mediterranean fever patients

  2023cites this paper
• Dyslipidemia in the Russian Federation: population data, associations with risk factors

  2023cites this paper
• Role of FGF21 and Leptin for the Diagnosis of Metabolic Health in Children with and without Obesity

  2023cites this paper
• Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol

  2023cites this paper
• Correlation of lipid profile and lipoprotein ratio with severity of diabetic foot ulcers

  2023cites this paper
• Assessment of Lipid Balance Parameters after Laparoscopic Sleeve Gastrectomy in 1-Year Observation

  2023influential citation
• Selenium Biomarkers and Their Relationship to Cardiovascular Risk Parameters in Obese Women

  2023cites this paper
• The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease

  2023cites this paper
• Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation

  2023cites this paper
• Subclinical atherosclerosis burden in non-diabetic hypertensives treated in primary care center: the IMTABI study

  2023cites this paper
• Consumption of Eggs Alone or Enriched with Annatto (Bixa orellana L.) Does Not Increase Cardiovascular Risk in Healthy Adults—A Randomized Clinical Trial, the Eggant Study

  2023influential citation
• The effect of perinatal HIV and antiretroviral therapy on vascular structure and function in young people: A systematic review and meta-analysis.

  2022cites this paper
• Statin therapy and lipids-lowering supplements – safe and effective treatment of lipids disturbances in children

  2022influential citation
• Cardiometabolic syndrome in HIV-positive and HIV-negative patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia: a comparative cohort study

  2022cites this paper
• Atherogenic index of plasma is an independent predictor of mitral annular calcification

  2022cites this paper
• Novel sedentary cage induced sedentariness in rats: evidence from relevant biomarkers

  2022cites this paper
• High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity

  2022influential citation
• Association of the Atherogenic Index of Plasma with C-Reactive Protein and Urinary Albumin Excretion in a Normotensive Nondiabetic Population

  2022cites this paper
• Switching palmitoyl and oleoyl positions in sn-2 and sn-3 of a triacylglycerol led to differential body weight gain rates and hepatic gene expressions in mice fed a high-fat diet

  2022cites this paper
• Therapeutic Effect of Hijamah (Cupping Therapy) on Lipid Profiles and Apolipoprotein in Hypercholesterolemic Patients

  2022influential citation
• Effects of hawthorn seed oil on plasma cholesterol and gut microbiota

  2022cites this paper
• Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice

  2022cites this paper
• Small dense low-density lipoprotein or low-density lipoprotein for cardiovascular disease in Indians: Meta-analysis addressing the diagnostic dilemma

  2022cites this paper
• The Prevalence of the Different Components of the Metabolic Syndrome (MetS) in Obese Nondiabetic Children and Young Adolescents and their Anthropometric Data in Relation to Parents

  2021cites this paper
• Cardiovascular Diseases in Obesity: What is the Role of Magnesium?

  2021cites this paper
• The association of the steatosis severity, NAFLD fibrosis score and FIB‐4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross‐sectional study

  2021cites this paper
• Effects of a Mediterranean Diet, Dairy, and Meat Products on Different Phenotypes of Dyslipidemia: A Preliminary Retrospective Analysis

  2021cites this paper
• Mass Spectrometry-Based Lipidomics Reveals Differential Changes in the Accumulated Lipid Classes in Chronic Kidney Disease

  2021cites this paper
• Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis

  2021cites this paper
• Assessment of sdLDL-C by Three Different Formula and Its Correlation with Clinical Variables Among Diabetes Individuals with and without Nephropathy

  2021cites this paper
• Association between apolipoprotein B and dietary fibers

  2021cites this paper
• Plasma atherogenic indices are independent predictors of slow coronary flow

  2021cites this paper
• Dislipidemia Aterogenik pada Pasien Diabetes Melitus Tipe 2: Patofisiologi dan Pilihan Terapi

  2021cites this paper
• Protective Effect of Costus afer Aqueous Leaf Extract (CALE) on Low-Dose Heavy Metal Mixture-Induced Alterations in Serum Lipid Profile and Hematological Parameters of Male Wistar Albino Rats

  2020cites this paper
• Anti-atherosclerotic effects of Eurycoma Longifolia (Tongkat Ali) in rats fed on high-fat diet

  2020cites this paper
• Functional differentiation and regulation of follicular T helper cells in inflammation and autoimmunity

  2020cites this paper
• Effects of virgin coconut oil consumption on metabolic syndrome components and asymmetric dimethylarginine: A randomized controlled clinical trial.

  2020cites this paper
• Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study

  2020cites this paper
• Small Dense Low-Density Lipoprotein as Risk Factor for Atherosclerosis in Type 2 Diabetes Mellitus

  2020cites this paper
• Assessment of The Effects Of Crude Metabolic Extracts (Leaf And Twig) of Loranthus Micranthus On Streptozotocin Induced Diabetic Rats

  2020cites this paper
• Effects of Aloe Vera and Swimming Training on Lipid Profile of Streptozotocin Induced Diabetic Rats

  2020cites this paper
• Modelling the prognostic effect of glucose and lipid profiles on stroke recurrence in Malaysia: an event-history analysis

  2020influential citation
• Comparative study of efficacy and safety of omega 3 fatty acids and fenofibrate with background atorvastatin therapy in patients of atherogenic dyslipidaemia

  2019influential citation
• Naringin abrogates HIV-1 protease inhibitors-induced atherogenic dyslipidemia and oxidative stress in vivo

  2019cites this paper
• Diets for weight loss and cardiovascular health in obesity

  2019influential citation
• Prevalence of dyslipidemia among students of a Yemeni University

  2019cites this paper
• Flavonoids: A Promising Therapy for Obesity Due to the High-Fat Diet

  2019cites this paper
• Insulin Resistance Index and Proatherogenic Lipid Indices in the Offspring of People with Diabetes

  2019cites this paper
• Association of total, acylated and unacylated ghrelin with apolipoprotein A1 and insulin concentrations in acromegalic patients.

  2019cites this paper
• Consuming Diet Supplemented with Either Red Wheat Bran or Soy Extract Changes Glucose and Insulin Levels in Female Obese Zucker Rats.

  2019cites this paper
• Relation between dyslipidemia and obesity: A concise review

  2019cites this paper
• The Role Of Primary Kinetoprophilaxy In Metabolic Disorders – Exogenous Obesity

  2019cites this paper
• Hyperlipidemic Platelets in Blood Donors: A Correlative Study in North Indian Population

  2019cites this paper
• Association of Single Nucleotide Polymorphisms with Dyslipidemia in Antiretroviral Exposed HIV Patients: A Case-Control Study in a Ghanaian population

  2019cites this paper
• High LDL levels lessen bone destruction during antigen-induced arthritis by inhibiting osteoclast formation and function.

  2019cites this paper
• Apolipoprotein B and angiotensin-converting enzyme polymorphisms and aerobic interval training: randomized controlled trial in coronary artery disease patients

  2018cites this paper
• The relationship between atherogenic index of plasma and major risk factors of cardiovascular disease in obese and non-obese individuals

  2018influential citation
• Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives

  2018cites this paper
• Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population

  2018cites this paper
• Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents

  2018cites this paper
• Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013)

  2018cites this paper
• Effect of Fiber-Rich Snacks on C-Reactive Protein and Atherogenic Index in Type 2 Diabetes Patients

  2018cites this paper
• Streptozotocin-induced diabetes in rats: effects of White Butterfly (Clerodendrum volubile) leaves on blood glucose levels, lipid profile and antioxidant status

  2018cites this paper
• Effect of Fiber-Rich Snacks on C-Reactive Protein and Atherogenic Index in Type 2 Diabetes Patients

  2018cites this paper
• Maternal olive oil intake enhances lipid metabolism and lipase activities in offspring of cafeteria diet-induced obese rats

  2018cites this paper
• Cognitive function in type 2 diabetes : a study using younger adults

  2017cites this paper
• Reducing Cardiovascular Disease Risk in Youth with Type 2 Diabetes Through Dietary Carbohydrate Restriction: Clinical and Molecular Perspectives

  2017cites this paper
• Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs

  2017cites this paper
• Serum Lipid Profile and Its Relationship with Carotid Intima-Media Thickness in Hypertensive Adults Attending a Tertiary Hospital in Southern Nigeria

  2017influential citation
• RASIO KADAR TRIGLISERIDA-KOLESTEROL HDL SERUM TINGGI MENINGKATKAN KEPARAHAN KLINIS PENDERITA STROKE ISKEMIK AKUT

  2017cites this paper
• Combined Effect of Vitamin C and E Dose on Type 2 Diabetes Patients

  2017cites this paper
• Knowledge of cardiovascular risk factors among medical students at king Abdulaziz university

  2017cites this paper
• Fibrates in the management of atherogenic dyslipidemia

  2017cites this paper
• Acute changes in blood lipid profiles and metabolic risk factors in collegiate elite taekwondo athletes after short-term de-training: a prospective insight for athletic health management

  2017cites this paper
• Cameroonian professional soccer players and risk of atherosclerosis

  2017cites this paper
• A COMPARATIVE CLINICAL STUDY ON EFFICACY OF BHAVITA AMALAKI CHOORNA AND SHUDDHA GUGGULU IN DYSLIPIDEMIA

  2016cites this paper
• Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans

  2016cites this paper